Indecainide (INN, trade name Decabid) is a class Ic antiarrhythmic agent.[1] Developed and marketed by Lilly, it has now been discontinued.

Indecainide
Clinical data
ATC code
  • none
Identifiers
  • 9-[3-(isopropylamino)propyl]-9H-fluorene-9-carboxamide
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC20H24N2O
Molar mass308.425 g·mol−1
3D model (JSmol)
  • O=C(N)C3(c1ccccc1c2c3cccc2)CCCNC(C)C
  • InChI=1S/C20H24N2O/c1-14(2)22-13-7-12-20(19(21)23)17-10-5-3-8-15(17)16-9-4-6-11-18(16)20/h3-6,8-11,14,22H,7,12-13H2,1-2H3,(H2,21,23) checkY
  • Key:UCEWGESNIULAGX-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

References

edit
  1. ^ Jaillon P, Drici M (December 1989). "Recent antiarrhythmic drugs". The American Journal of Cardiology. 64 (20): 65J–69J. doi:10.1016/0002-9149(89)91203-4. PMID 2688391.
edit
  • FDA drug details [1]